Our Team

Vanessa Malier

Strategic Advisor

Vanessa Malier is a member of the executive board of Kurma Partners. After completing her studies in biology, Vanessa began her career working as an analyst at CDC Innovation before joining a California-based start-up where she was responsible for business development.

In 2003, Vanessa joined Ipsen as strategic adviser to the CEO before being appointed Product Leader for febuxostat, which was approved by the EMA in 2008. She was appointed Senior Director, Business Development (Oncology) in 2009 and subsequently VP, R&D Strategic Planning in 2011.

Vanessa is a graduate of Ecole Normale Supérieure de Cachan and has a degree in immunology from Institut Pasteur. Vanessa joined Kurma in September 2013 and is responsible for its investment in Xeltis (Switzerland).